Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 1 open-market purchase and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Lipocine Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 44 | 46 | +2 |
| Shares | 11.9M | 11.9M | −9.44K (−0.1%) |
| Value | $16.2M | $9.54M | −$6.62M (−41.0%) |
New holders (9)
Institutions that held Lipocine Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 200,066 | $160.0K | 0.00% |
| Acadian Asset Management LLC | 85,070 | $68.0K | 0.00% |
| Bailard, Inc. | 74,400 | $60.0K | 0.00% |
| Carson Advisory Inc. | 52,000 | $42.0K | 0.05% |
| Merit Financial Group, LLC | 29,900 | $24.0K | 0.00% |
| Ground Swell Capital, LLC | 20,152 | $16.0K | 0.03% |
| Snowden Capital Advisors LLC | 12,578 | $10.0K | 0.00% |
| Raymond James & Associates | 10,902 | $9.00K | 0.00% |
| Truvestments Capital LLC | 1,407 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Lipocine Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| EAM Investors, LLC | 657,804 | $901.0K |
| Virtu Financial LLC | 124,550 | $171.0K |
| Citadel Advisors LLC | 63,135 | $86.0K |
| XTX Topco Ltd | 39,357 | $54.0K |
| Two Sigma Securities, LLC | 18,905 | $26.0K |
| Tower Research Capital LLC (TRC) | 8,554 | $12.0K |
| Citigroup Inc | 500 | $1.00K |